Superbug Risk to War Wounded

Article

Soldiers who survive severe injuries on battlefields such as those in Iraq and Afghanistan can be at risk from developing infections of their wounds with multidrug-resistant bacteria. The potentially lethal microbes include superbugs such as methicillin-resistant Staphylococcus aureus (MRSA), Acinetobacter baumannii, Pseudomonas aeruginosa, Klebsiella species and Escherichia coli.

Dr. Clinton K. Murray, from Brooke Army Medical Center, told the Society for General Microbiology Meeting at the International Centre, Harrogate, that at the beginning of the 20th century improved military hygiene and disease control led to a steady decline in the number of wartime deaths attributable to infections classically known as "war pestilence," which included cholera, dysentery, plague, smallpox, typhoid, and typhus fever.

"The development of more effective personal protective equipment, as well as training medics to provide life-saving procedures on the battlefield, has greatly improved survival rates," said Murray. "Positioning surgical and advanced medical care nearer to the point of injury has also enabled casualties to survive near-catastrophic wounds. But even though combat casualties are surviving these severe injuries, they risk developing wound infections. Microbes on the casualty's skin can be introduced into the wound at the time of injury or during subsequent medical care."

Although most of the infections can be treated with standard antibiotics, some of them may be caused by pathogens resistant to many if not all of these drugs. This requires clinicians to prescribe less commonly used antibiotics such as colistin. Modern microbiology and antimicrobial agents can do a lot but hospital infection control even in a war zone is of essential importance.

Recent Videos
Lindsay K. Weir, MPH, CIC, Lead Infection Preventionist/Infection Preventionist III
•	Rebecca (Bartles) Crapanzano-Sigafoos, DrPH, MPH, CIC, FAPIC (corresponding author), executive director of APIC’s Center for Research, Practice, and Innovation, and lead author of the study.
Infection Control Today's Infection Intel: Staying Ahead With Company Updates and Product Innovations.
COVID-19 presentations at IDWeek in Las Angeles, California by Invivyd.   (Adobe Stock 333039083 by Production Perig)
Long COVID and Other Post-Viral Syndromes
Meet Jenny Hayes, MSN, RN, CIC, CAIP, CASSPT.
Infection Control Today Editorial Advisory Board: Fibi Attia, MD, MPH, CIC.
Andrea Thomas, PhD, DVM, MSc, BSc, director of epidemiology at BlueDot
mpox   (Adobe Stock 924156809 by Andreas Prott)
Meet Alexander Sundermann, DrPH, CIC, FAPIC.
Related Content